We also discovered that three peripheral blood immune cell types from PD patients had significantly lower levels of an inhibitor of NFκB, RGS10: CD16+ and CD14+ CD16+ monocytes—which had the highest average levels of RGS10—and CD4+ T-cells. Here, RGS10 is linked to Parkinson disease.